Kared et al. [14] found that, in acute hepatitis C, the signaling pathway mediated by Tim-3 could inhibit IL-21 secreted by Th17 cells and enhance the function of regulatory T cells, thus protecting the body from damage caused by the excessive immune-inflammatory response [15]. The gene discussed is HAVCR2; the disease is hepatitis C virus infection.